Cleavage Site Mutant As a Potential Vaccine

  • Morio Homma


Cleavage of the envelope glycoprotein of paramyxoviruses [1–3] and influenza viruses [4–7] is accomplished by a host protease. By this means, virus becomes activated, causes hemolysis, cell fusion, and infectivity. The presence of the protease allows the virus to replicate in multiple cycles. In contrast, in the absence of protease, replication is limited to a single cycle.


Newcastle Disease Virus Progeny Virus Tissue Culture Cell Sendai Virus Potential Vaccine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Homma M, Ohuchi M (1973) Trypsin action on the growth of Sendai virus in tissue culture cells. III. Structural difference of Sendai virus grown in eggs and in tissue culture cells. J Virol 12: 1457–1465PubMedCentralPubMedGoogle Scholar
  2. 2.
    Scheid A, Choppin PW (1974) Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis and infectivity by proteolytic cleavage of an inactive precursor protein of Sendai virus. Virology 57: 475–490PubMedCrossRefGoogle Scholar
  3. 3.
    Nagai Y, Klenk H-D, Rott R (1976) Proteolytic cleavage of viral glycoproteins and its significance for the virulence of Newcastle disease virus. Virology 72: 494–508PubMedCrossRefGoogle Scholar
  4. 4.
    Lazarowitz SG, Compans RW, Choppin PW (1971) Influenza virus structural and non-structural proteins in infected cells and their plasma membranes. Virology 46: 830–843PubMedCrossRefGoogle Scholar
  5. 5.
    Klenk H-D, Rott R, Orlich M, Bloedorn J (1975) Activation of influenza A viruses by trypsin treatment. Virology 68: 426–439PubMedCrossRefGoogle Scholar
  6. 6.
    Lazarowitz SG, Choppin PW (1975) Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide. Virology 68: 440–454PubMedCrossRefGoogle Scholar
  7. 7.
    Garten W, Bosch FX, Linder D, Rott R, Klenk H-D (1981) Proteolytic activation of the influenza virus hemagglutinin: The structure of the cleavage site and the enzyme involved in cleavage. Virology 115: 361–374PubMedCrossRefGoogle Scholar
  8. 8.
    Scheid A, Caliguiri LA, Compans RW, Choppin PW (1972) Isolation of myxovirus glycoproteins. Association of both hemagglutinating and neuraminidase activities with the larger SV5 glycoprotein. Virology 50: 640–652PubMedCrossRefGoogle Scholar
  9. 9.
    Tozawa H, Watanabe M, Ishida N (1973) Structural components of Sendai virus. Serological and physicochemical characterization of hemagglutinin subunit associated with neuraminidase activity. Virology 55: 242–253PubMedCrossRefGoogle Scholar
  10. 10.
    Scheid A, Choppin PW (1974) The hemagglutinating and neuraminidase (HN) protein of a paramyxovirus: Interaction of neuraminic acid in affinity chromotography. Virology 62: 125–133PubMedCrossRefGoogle Scholar
  11. 11.
    Scheid A, Graves MC, Silver SM, Choppin PW (1978) Studies on the structure and functions of paramyxovirus glycoproteins. In Mahy BWJ, Barry RD (eds) Negative Strand Viruses and the Host Cell. Academic Press, London, p 181Google Scholar
  12. 12.
    Muramatsu M, Homma M (1980) Trypsin action on the growth of Sendai virus in tissue culture cells. V. An activating enzyme for Sendai virus in the chorioallantoic fluid of the embryonated chicken eggs. Microbiol Immunol 24: 113–122PubMedCrossRefGoogle Scholar
  13. 13.
    Silver SM, Scheid A, Choppin PW (1978) Loss on serial passage of rhesus monkey kidney cells of proteolytic activity required for Sendai virus activation. Infect Immun 20: 235–241PubMedCentralPubMedGoogle Scholar
  14. 14.
    Ishida N, Homma M (1978) Sendai virus. Adv Virus Res 23: 349–383PubMedCrossRefGoogle Scholar
  15. 15.
    Garten W, Berk W, Nagai Y, Rott R, Klenk H-D (1980) Mutational changes of the protease susceptibility of glycoprotein F of Newcastle disease virus: Effect on pathogenicity. J Gen Virol 50: 135–147PubMedCrossRefGoogle Scholar
  16. 16.
    Takano M, Itoh Y, Maeno K, Shimokata K, Yamamoto T, Hara K, Iijma S (1980) In vivo distribution of cells with virus receptor. 2. Distribution of cells with HVJ-receptor. ( In Japanese ). Abstracts of the General Meeting of the Society of Japanese Virologists p. 2027Google Scholar
  17. 17.
    Tashiro M, Homma M (1983) Pneumotropism of Sendai virus in relation to protease-mediated activation in mouse lungs. Infect Immun 39: 879–888PubMedCentralPubMedGoogle Scholar
  18. 18.
    Tashiro M, Homma M (1983) Evidence of proteolytic activation of Sendai virus in mouse lung. Arch Virol 77: 127–137PubMedCrossRefGoogle Scholar
  19. 19.
    Scheid A, Choppin PW (1976) Protease activation mutants of Sendai virus: Activation of biological properties by specific proteases. Virology 69: 265–277PubMedCrossRefGoogle Scholar
  20. 20.
    Tashiro M, Homma M (1985) Protection of mice from wild-type Sendai virus infection by a trypsin-resistant mutant, TR-2. J Virol 53: 228–234PubMedCentralPubMedGoogle Scholar
  21. 21.
    Green GM, Jakab GJ, Low RB, Davis GS (1977) Defense mechanism of the respiratory membrane. Am Rev Respir Dis 115: 479–514PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1986

Authors and Affiliations

  • Morio Homma

There are no affiliations available

Personalised recommendations